OXSM
3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial
Also known as: CEM1, FASN2D, FLJ20604, KS, OXSM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NWU1
- Gene
- OXSM
- Ensembl
- ENSG00000151093
- Chromosome
- 3
- Canonical length
- 459 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria,Cytosol
OverviewNCBI Gene
This gene encodes a beta-ketoacyl synthetase. The encoded enzyme is required for elongation of fatty acid chains in the mitochondria. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2009]
Canonical amino-acid sequenceUniProt
459 residues, UniProt reviewed canonical sequence.
>Q9NWU1|OXSM
1 MSNCLQNFLK ITSTRLLCSR LCQQLRSKRK FFGTVPISRL HRRVVITGIG LVTPLGVGTH
61 LVWDRLIGGE SGIVSLVGEE YKSIPCSVAA YVPRGSDEGQ FNEQNFVSKS DIKSMSSPTI
121 MAIGAAELAM KDSGWHPQSE ADQVATGVAI GMGMIPLEVV SETALNFQTK GYNKVSPFFV
181 PKILVNMAAG QVSIRYKLKG PNHAVSTACT TGAHAVGDSF RFIAHGDADV MVAGGTDSCI
241 SPLSLAGFSR ARALSTNSDP KLACRPFHPK RDGFVMGEGA AVLVLEEYEH AVQRRARIYA
301 EVLGYGLSGD AGHITAPDPE GEGALRCMAA ALKDAGVQPE EISYINAHAT STPLGDAAEN
361 KAIKHLFKDH AYALAVSSTK GATGHLLGAA GAVEAAFTTL ACYYQKLPPT LNLDCSEPEF
421 DLNYVPLKAQ EWKTEKRFIG LTNSFGFGGT NATLCIAGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OXSM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- liver: 21 nTPM
- tongue: 15 nTPM
- skeletal muscle: 14 nTPM
- epididymis: 13 nTPM
- kidney: 13 nTPM
- heart muscle: 12 nTPM
Single-cell type
- cardiomyocytes: 268 nCPM
- early spermatids: 168 nCPM
- late spermatids: 148 nCPM
- late primary spermatocytes: 140 nCPM
- epicardial cells: 75 nCPM
- pancreatic acinar cells: 36 nCPM
Immune cell
- NK-cell: 11 nTPM
- memory CD8 T-cell: 11 nTPM
- naive CD8 T-cell: 11 nTPM
- naive CD4 T-cell: 10 nTPM
- MAIT T-cell: 10 nTPM
- memory CD4 T-cell: 8.9 nTPM
Brain region
- choroid plexus: 7.2 nTPM
- hypothalamus: 3.4 nTPM
- cerebellum: 3.3 nTPM
- thalamus: 3.2 nTPM
- basal ganglia: 3.1 nTPM
- cerebral cortex: 3.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OXSM.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 64 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.02
- DepMap mean gene effect
- -0.24
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acyl-CoA metabolic process
- fatty acid biosynthetic process
- medium-chain fatty acid biosynthetic process
- short-chain fatty acid biosynthetic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Beta-ketoacyl synthase-like, N-terminal domain
- Beta-ketoacyl synthase, C-terminal domain
- Thiolase-like
- Beta-ketoacyl synthase, active site
- Polyketide synthase, beta-ketoacyl synthase domain
- Beta-ketoacyl synthase, N-terminal domain
- Beta-ketoacyl synthase, C-terminal domain
- Beta-ketoacyl synthase
- 3-oxoacyl-[acyl-carrier-protein] synthase 2
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OXSM as an antibody target. Whether an autoantibody or antibody against OXSM could matter depends on whether native OXSM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OXSM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OXSM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...